These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 9789956)
1. Erythropoietin mRNA in hepatocellular carcinomas and kidney in male B6C3F1 mice with secondary polycythemia. Horinouchi A; Miyamoto S; Sekiguchi M; Doi H; Okazaki S; Ando T Toxicol Pathol; 1998; 26(5):682-6. PubMed ID: 9789956 [TBL] [Abstract][Full Text] [Related]
2. Secondary polycythemia in male B6C3F1 mice with spontaneously occurring hepatocellular carcinomas. Horinouchi A; Hayashi S; Ando T; Nonoyama T Toxicol Pathol; 1997; 25(5):511-5. PubMed ID: 9323843 [TBL] [Abstract][Full Text] [Related]
3. A novel biological function of soluble biglycan: Induction of erythropoietin production and polycythemia. Frey H; Moreth K; Hsieh LT; Zeng-Brouwers J; Rathkolb B; Fuchs H; Gailus-Durner V; Iozzo RV; de Angelis MH; Schaefer L Glycoconj J; 2017 Jun; 34(3):393-404. PubMed ID: 27600268 [TBL] [Abstract][Full Text] [Related]
4. Erythropoietin production in hepatocellular carcinoma cells associated with polycythemia: immunohistochemical evidence. Sakisaka S; Watanabe M; Tateishi H; Harada M; Shakado S; Mimura Y; Gondo K; Yoshitake M; Noguchi K; Hino T Hepatology; 1993 Dec; 18(6):1357-62. PubMed ID: 7694895 [TBL] [Abstract][Full Text] [Related]
5. Gene expression of erythropoietin in hepatocellular carcinoma. Muta H; Funakoshi A; Baba T; Uike N; Wakasugi H; Kozuru M; Jimi A Intern Med; 1994 Jul; 33(7):427-31. PubMed ID: 7524823 [TBL] [Abstract][Full Text] [Related]
6. Gene expression of mutant erythropoietin in hepatocellular carcinoma. Funakoshi A; Muta H; Baba T; Shimizu S Biochem Biophys Res Commun; 1993 Sep; 195(2):717-22. PubMed ID: 8396923 [TBL] [Abstract][Full Text] [Related]
7. NTP Toxicology and Carcinogenesis Studies of C.I. Direct Blue 218 (CAS No. 28407-37-6) in F344/N Rats and B6C3F1 Mice (Feed Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1994 Feb; 430():1-280. PubMed ID: 12616301 [TBL] [Abstract][Full Text] [Related]
8. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289 [TBL] [Abstract][Full Text] [Related]
9. [A case of erythropoietin-producing renal cell carcinoma with polycythemia]. Okuyama M; Nishihara M; Hashimoto H; Kaneko S; Yachiku S Hinyokika Kiyo; 2002 Sep; 48(9):531-4. PubMed ID: 12402477 [TBL] [Abstract][Full Text] [Related]
10. Erythropoietin production by a hepatic adenoma in a patient with severe erythrocytosis. Vik A; Cui G; Isaksen V; Wik T; Hansen JB Acta Haematol; 2009; 121(1):52-5. PubMed ID: 19339771 [TBL] [Abstract][Full Text] [Related]
11. Erythropoietin and the control of red cell production. Graber SE; Krantz SB Annu Rev Med; 1978; 29():51-66. PubMed ID: 206191 [No Abstract] [Full Text] [Related]
12. NTP Toxicology and Carcinogenesis Studies of o-Nitroanisole (CAS No. 91-23-6) in F344 Rats and B6C3F1 Mice (Feed Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1993 May; 416():1-482. PubMed ID: 12616295 [TBL] [Abstract][Full Text] [Related]
13. Toxicology and Carcinogenesis Studies of 5,5-Diphenylhydantoin (CAS No. 57-41-0) (Phenytoin) in F344/N Rats and B6C3F1 Mice (Feed Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1993 Nov; 404():1-303. PubMed ID: 12621514 [TBL] [Abstract][Full Text] [Related]
14. Erythropoietin gene expression in renal carcinoma is considerably more frequent than paraneoplastic polycythemia. Wiesener MS; Münchenhagen P; Gläser M; Sobottka BA; Knaup KX; Jozefowski K; Jürgensen JS; Roigas J; Warnecke C; Gröne HJ; Maxwell PH; Willam C; Eckardt KU Int J Cancer; 2007 Dec; 121(11):2434-42. PubMed ID: 17640059 [TBL] [Abstract][Full Text] [Related]
15. [Assessment of the erythropoietin-producing function of the kidney and liver under controlled perfusion]. Nefedov VP; Makarov VP; Tashenov EK; Krizhanovskaia EV; Kazakov VN Biull Eksp Biol Med; 1986 Oct; 102(10):404-6. PubMed ID: 3768502 [TBL] [Abstract][Full Text] [Related]
16. Neuroblastoma with expression of erythropoietin resulting in erythrocytosis. Wang LY; Shih LY; Chen SH; Liu HC; Chai IJ; Liang DC J Pediatr Hematol Oncol; 2003 Aug; 25(8):649-50. PubMed ID: 12902921 [TBL] [Abstract][Full Text] [Related]
17. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653 [TBL] [Abstract][Full Text] [Related]
18. Production of erythropoietin and multiple cytokines by metanephric adenoma results in erythrocytosis. Yoshioka K; Miyakawa A; Ohno Y; Namiki K; Horiguchi Y; Murai M; Mukai M; Tachibana M Pathol Int; 2007 Aug; 57(8):529-36. PubMed ID: 17610479 [TBL] [Abstract][Full Text] [Related]
19. Translation of messenger RNA from a renal tumor into a product with the biological properties of erythropoietin. Saito T; Saito K; Trent DJ; Draganac PS; Andrews RB; Farkas WR; Dunn CD; Etkin LD; Lange RD Exp Hematol; 1985 Jan; 13(1):23-8. PubMed ID: 4038660 [TBL] [Abstract][Full Text] [Related]
20. Ontogeny of erythropoietin mRNA expression in liver, kidneys and testes of the foetal and the neonatal pig. David RB; Sjaastad OV; Blom AK; Skogtvedt S; Opsata M; Harbitz I Comp Biochem Physiol B Biochem Mol Biol; 2002 Mar; 131(3):527-33. PubMed ID: 11959035 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]